The KCNB1 gene plays a crucial role in the proper functioning of the nervous system, and mutations in this gene are associated with early infantile epileptic encephalopathy type 26 (EIEE26). This condition is characterized by frequent seizures that begin in infancy, along with various degrees of developmental delay and sometimes additional neurological symptoms. Given the significant impact this condition can have on affected individuals and their families, genetic testing for mutations in the KCNB1 gene is an important diagnostic tool.

DNA Labs UAE offers a specialized genetic test aimed at identifying mutations within the KCNB1 gene to confirm a diagnosis of early infantile epileptic encephalopathy type 26. This test is crucial for affected families, as it not only aids in the diagnosis but also helps in guiding treatment decisions and understanding the prognosis. Furthermore, it can provide valuable information for genetic counseling, particularly for family planning and assessing the risk of recurrence in future pregnancies.

The test cost is 4400 AED, reflecting the specialized nature of the genetic analysis and the expertise required to accurately interpret the results. Conducted in a state-of-the-art laboratory by professionals skilled in genetic diagnostics, this test represents a significant step forward for families seeking answers in the face of challenging neurological conditions.